GAL3 Protein Expression is Related to Clinical Features of Prolactin-Secreting Pituitary Microadenoma and Predicts its Recurrence after Surgical Treatment

Background: Previous in vitro study showed that Galectin-3 (Gal-3) protein plays an important role in pituitary tumorigenesis, however, the association of Gal-3 expression with the clinical feature and prognosis of pituitary tumor in a clinical setting remains unknown. Methods: We enrolled 220 patie...

Full description

Bibliographic Details
Main Authors: Dongwei Dai, Ya'nan Li, Qiong Lu, Longyang Yu, Weijie Min, Laixing Wang, Yiqun Cao, Zhijian Yue
Format: Article
Language:English
Published: Cell Physiol Biochem Press GmbH & Co KG 2014-04-01
Series:Cellular Physiology and Biochemistry
Subjects:
Online Access:http://www.karger.com/Article/FullText/358673
_version_ 1811267144366686208
author Dongwei Dai
Ya'nan Li
Qiong Lu
Longyang Yu
Weijie Min
Laixing Wang
Yiqun Cao
Zhijian Yue
author_facet Dongwei Dai
Ya'nan Li
Qiong Lu
Longyang Yu
Weijie Min
Laixing Wang
Yiqun Cao
Zhijian Yue
author_sort Dongwei Dai
collection DOAJ
description Background: Previous in vitro study showed that Galectin-3 (Gal-3) protein plays an important role in pituitary tumorigenesis, however, the association of Gal-3 expression with the clinical feature and prognosis of pituitary tumor in a clinical setting remains unknown. Methods: We enrolled 220 patients with prolactin-secreting pituitary adenomas (PA) who previously had transsphenoidal pituitary surgery. The Gal-3 expression was detected in the patients' PA samples using immunohistochemistry and those patients were followed up. A prolactin-secreting PA cell line, the MMQ cell line, was used to study the in vitro effect of Gal-3 on proliferation, migration and invasion of PA cells using small interfering RNA (siRNA) transfecton technique. The in vivo tumorgenesis in nude mice was also studied. Results: We found that Gal-3 expression was not related to age and sex, but positively associated with tumor invasion (Pin vitro studies showed that Gal-3 knock-down by the siRNA technique significantly inhibited the proliferation, migration and invasion ability of the MMQ cells, whereas Gal-3 siRNA transfection induced apoptosis of the MMQ cells. The in vivo tumorgenesis assay showed that Gal-3 siRNA transfection significantly inhibited the tumor volume in vivo compared to transfection of the control siRNA (PConclusion: Gal-3 regulates proliferation, apoptosis, migration and invasion of the MMQ cells. Gal-3 may be used as a tissue marker to evaluate the clinical feature and prognosis of PA patients.
first_indexed 2024-04-12T20:56:07Z
format Article
id doaj.art-aa4b93aa9b6c416781789115cb1fab86
institution Directory Open Access Journal
issn 1015-8987
1421-9778
language English
last_indexed 2024-04-12T20:56:07Z
publishDate 2014-04-01
publisher Cell Physiol Biochem Press GmbH & Co KG
record_format Article
series Cellular Physiology and Biochemistry
spelling doaj.art-aa4b93aa9b6c416781789115cb1fab862022-12-22T03:16:59ZengCell Physiol Biochem Press GmbH & Co KGCellular Physiology and Biochemistry1015-89871421-97782014-04-013341026103510.1159/000358673358673GAL3 Protein Expression is Related to Clinical Features of Prolactin-Secreting Pituitary Microadenoma and Predicts its Recurrence after Surgical TreatmentDongwei DaiYa'nan LiQiong LuLongyang YuWeijie MinLaixing WangYiqun CaoZhijian YueBackground: Previous in vitro study showed that Galectin-3 (Gal-3) protein plays an important role in pituitary tumorigenesis, however, the association of Gal-3 expression with the clinical feature and prognosis of pituitary tumor in a clinical setting remains unknown. Methods: We enrolled 220 patients with prolactin-secreting pituitary adenomas (PA) who previously had transsphenoidal pituitary surgery. The Gal-3 expression was detected in the patients' PA samples using immunohistochemistry and those patients were followed up. A prolactin-secreting PA cell line, the MMQ cell line, was used to study the in vitro effect of Gal-3 on proliferation, migration and invasion of PA cells using small interfering RNA (siRNA) transfecton technique. The in vivo tumorgenesis in nude mice was also studied. Results: We found that Gal-3 expression was not related to age and sex, but positively associated with tumor invasion (Pin vitro studies showed that Gal-3 knock-down by the siRNA technique significantly inhibited the proliferation, migration and invasion ability of the MMQ cells, whereas Gal-3 siRNA transfection induced apoptosis of the MMQ cells. The in vivo tumorgenesis assay showed that Gal-3 siRNA transfection significantly inhibited the tumor volume in vivo compared to transfection of the control siRNA (PConclusion: Gal-3 regulates proliferation, apoptosis, migration and invasion of the MMQ cells. Gal-3 may be used as a tissue marker to evaluate the clinical feature and prognosis of PA patients.http://www.karger.com/Article/FullText/358673Galectin-3Pituitary adenomasPrognosis
spellingShingle Dongwei Dai
Ya'nan Li
Qiong Lu
Longyang Yu
Weijie Min
Laixing Wang
Yiqun Cao
Zhijian Yue
GAL3 Protein Expression is Related to Clinical Features of Prolactin-Secreting Pituitary Microadenoma and Predicts its Recurrence after Surgical Treatment
Cellular Physiology and Biochemistry
Galectin-3
Pituitary adenomas
Prognosis
title GAL3 Protein Expression is Related to Clinical Features of Prolactin-Secreting Pituitary Microadenoma and Predicts its Recurrence after Surgical Treatment
title_full GAL3 Protein Expression is Related to Clinical Features of Prolactin-Secreting Pituitary Microadenoma and Predicts its Recurrence after Surgical Treatment
title_fullStr GAL3 Protein Expression is Related to Clinical Features of Prolactin-Secreting Pituitary Microadenoma and Predicts its Recurrence after Surgical Treatment
title_full_unstemmed GAL3 Protein Expression is Related to Clinical Features of Prolactin-Secreting Pituitary Microadenoma and Predicts its Recurrence after Surgical Treatment
title_short GAL3 Protein Expression is Related to Clinical Features of Prolactin-Secreting Pituitary Microadenoma and Predicts its Recurrence after Surgical Treatment
title_sort gal3 protein expression is related to clinical features of prolactin secreting pituitary microadenoma and predicts its recurrence after surgical treatment
topic Galectin-3
Pituitary adenomas
Prognosis
url http://www.karger.com/Article/FullText/358673
work_keys_str_mv AT dongweidai gal3proteinexpressionisrelatedtoclinicalfeaturesofprolactinsecretingpituitarymicroadenomaandpredictsitsrecurrenceaftersurgicaltreatment
AT yananli gal3proteinexpressionisrelatedtoclinicalfeaturesofprolactinsecretingpituitarymicroadenomaandpredictsitsrecurrenceaftersurgicaltreatment
AT qionglu gal3proteinexpressionisrelatedtoclinicalfeaturesofprolactinsecretingpituitarymicroadenomaandpredictsitsrecurrenceaftersurgicaltreatment
AT longyangyu gal3proteinexpressionisrelatedtoclinicalfeaturesofprolactinsecretingpituitarymicroadenomaandpredictsitsrecurrenceaftersurgicaltreatment
AT weijiemin gal3proteinexpressionisrelatedtoclinicalfeaturesofprolactinsecretingpituitarymicroadenomaandpredictsitsrecurrenceaftersurgicaltreatment
AT laixingwang gal3proteinexpressionisrelatedtoclinicalfeaturesofprolactinsecretingpituitarymicroadenomaandpredictsitsrecurrenceaftersurgicaltreatment
AT yiquncao gal3proteinexpressionisrelatedtoclinicalfeaturesofprolactinsecretingpituitarymicroadenomaandpredictsitsrecurrenceaftersurgicaltreatment
AT zhijianyue gal3proteinexpressionisrelatedtoclinicalfeaturesofprolactinsecretingpituitarymicroadenomaandpredictsitsrecurrenceaftersurgicaltreatment